Several women are seeking compensation for side effects they have experienced allegedly as a result of the oral contraceptive sold as Yaz or Yasmin. They are seeking compensatory, punitive, and exemplary damages from drug maker Bayer, based on claims that the popular fourth-generation birth control... Read More

A new plaintiff has filed suit against Propecia's drug maker Merck & Co. The plaintiff filed his lawsuit in the ongoing multidistrict litigation case which is proceeding in the Eastern District of New York, in Brooklyn. This multidistrict litigation case combines a large number of... Read More

A new Zimmer hip implant lawsuit was filed in federal court in Newark, New Jersey, by Richard and Bonnie Weiner. The couple claims that Bonnie's defective Zimmer Durom Cup hip replacement devices caused her serious complications that include metallosis. Eventually, Bonnie received surgery to remove... Read More

Illinois resident John M. Paczokowski has become one of the most recent plaintiffs to join multidistrict litigation in New York after experiencing problems with a Zimmer knee replacement device. The plaintiff is seeking compensation based on claims he is making of strict liability, negligence, and... Read More

On September 14, 2012, a GranuFlo litigation was filed against Fresenius, the manufacturer of GranuFlo and NaturaLyte. The case alleges wrongful death of a woman who died after having a cardiovascular event following a hemodialysis treatment that used GranuFlo. Her next of kin brought the... Read More

The dialysis products GranuFlo and NaturaLyte, both manufactured and distributed by the German-based company Fresenius Medical Care, have been linked to life-threatening side effects including heart attack, arrhythmia, and stroke. On June 27, 2012, the FDA issued a Class 1 recall of NaturaLyte and GranuFlo,... Read More

New studies are indicating that side effects related to the antidepressant Zoloft could manifest in children as problems in language development. The study was published online yb the Proceedings the National Academy of Sciences of the United States of America on October 8. It explored... Read More

The Institute for Safe Medicine Practices issued a warning for the blood thinner Xarelto at the beginning of October. The ISMP cited a higher than expected risk of blood clots associated with the medication, and the warning come shortly after one that the FDA issued... Read More